BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31529309)

  • 21. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
    Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
    Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
    Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
    Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
    Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.
    Liu Y; Xiong Z; Beasley A; D'Amico T; Chen XL
    Ann N Y Acad Sci; 2016 Oct; 1381(1):66-73. PubMed ID: 27399176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
    Gao H; Teng C; Huang W; Peng J; Wang C
    Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.
    Maehara R; Fujikura K; Takeuchi K; Akita M; Abe-Suzuki S; Karbanová J; Corbeil D; Itoh T; Kakeji Y; Zen Y
    Mod Pathol; 2018 Jan; 31(1):83-92. PubMed ID: 28862264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
    Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
    Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
    Konishi T; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Am J Pathol; 2019 Oct; 189(10):1973-1985. PubMed ID: 31323188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2.
    Li J; Sang M; Zheng Y; Meng L; Gu L; Li Z; Liu F; Wu Y; Li W; Shan B
    Exp Cell Res; 2021 Dec; 409(1):112891. PubMed ID: 34688610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
    Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
    Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
    Chen W; Li Y; Yuan D; Peng Y; Qin J
    Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
    Wu Z; Zhou J; Zhang X; Zhang Z; Xie Y; Liu JB; Ho ZV; Panda A; Qiu X; Cejas P; Cañadas I; Akarca FG; McFarland JM; Nagaraja AK; Goss LB; Kesten N; Si L; Lim K; Liu Y; Zhang Y; Baek JY; Liu Y; Patil DT; Katz JP; Hai J; Bao C; Stachler M; Qi J; Ishizuka JJ; Nakagawa H; Rustgi AK; Wong KK; Meyerson M; Barbie DA; Brown M; Long H; Bass AJ
    Nat Genet; 2021 Jun; 53(6):881-894. PubMed ID: 33972779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma.
    Li Y; Li J; Luo M; Zhou C; Shi X; Yang W; Lu Z; Chen Z; Sun N; He J
    Cancer Lett; 2018 Aug; 430():57-66. PubMed ID: 29763634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
    Jiang L; Wang W; Li G; Sun C; Ren Z; Sheng H; Gao H; Wang C; Yu H
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):333-9. PubMed ID: 27329359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
    Zhang Z; Xiong R; Li C; Xu M; Guo M
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
    Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
    Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diethylhexyl phthalate (DEHP) regulates the proliferation and chemosensitivity of esophageal squamous cell carcinoma cells via regulation of PTEN.
    Zhu J; Zhang X; Wen B; Chen J; Lu Y; Xu W
    Hum Cell; 2021 Jul; 34(4):1153-1162. PubMed ID: 33721218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.